Podcasts about multidisciplinary

Master MASLD/MASH diagnosis and multidisciplinary care. Credit available for this activity expires: 07/07/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/diagnosing-and-managing-obesity-linked-liver-disease-2026a1000ki0?ecd=bdc_podcast_libsyn_mscpedu

Sabina Wantoch PhD is a researcher, facilitator, consultant, artist and animist. They are an Honorary Associate Professor at the Centre for Multidisciplinary & Intercultural Inquiry at University College London, a consultant in peer support for mental health with Imroc, and co-founder of The Mad Psychedelics Collaboratory. Their work centres around madness and its porous intersections with varieties of altered states, as well as entanglements between paradigms and conceptual structures. Our conversation covers intersubjectivity and shared perception, reducing the fear of madness, the reciprocal nature of mythos, the varieties of meaning and sense-making, and the importance of equanimity.Sabina then shares three symbols they've created; the Net, the Bog, and the Crossroads. Inspired by tarot, these accompany their PhD thesis and form part of Sabina's upcoming deck that represents the mad experience.Link to Sabina's research.

A multidisciplinary literature review and textual analysis of Moses and John the Beloved.mp3AbstractThis study examines the figures of Moses and John the Beloved as agents of cultural transmission, theological continuity, and communal identity formation within the biblical tradition through an interdisciplinary framework integrating biblical theology, cultural anthropology, sociology of religion, symbolic interactionism, and social learning theory. Particular attention is given to distinguishing John the Beloved from John the Baptist, whose prophetic ministry functioned primarily as preparation for the coming of Christ rather than the theological and ecclesial formation associated with the Johannine tradition (Bible Analysis, n.d.; Bibles.chat, n.d.). Whereas John the Baptist proclaimed repentance and inaugurated the messianic age through public witness, John the Beloved contributed to the development of early Christian identity through theological reflection, eyewitness testimony, and authorship traditionally associated with the Gospel of John, the Johannine Epistles, and Revelation (Bible Analysis, n.d.; Religion Answers, n.d.).Drawing upon anthropological understandings of culture as systems of shared meaning and symbolic practice (Geertz, 1973; Hofstede et al., 2010), alongside sociological perspectives concerning the social construction of reality and the institutionalization of knowledge (Berger & Luckmann, 1966), this study argues that divine revelation is transmitted not solely through doctrinal proclamation but also through ritual participation, language, narrative, education, and collective memory. Social learning theory further illuminates the mechanisms through which religious beliefs and practices are preserved across generations through observation, imitation, mentoring, and communal participation (Bandura, 1977).Within this framework, Moses emerges as the principal architect of Israel's covenantal identity, establishing the legal, liturgical, and ethical structures that shaped the religious consciousness of ancient Israel (Brueggemann, 1997). John the Beloved occupies a parallel role within early Christianity by interpreting the significance of Jesus Christ in ways that enabled the preservation and expansion of apostolic witness throughout the culturally diverse environment of the Greco-Roman world (Bauckham, 2006; Keener, 2003). Together, these figures represent complementary models of religious preservation and theological development: Moses as mediator of covenant formation and John as interpreter of Christian revelation.The study further evaluates contemporary interpretive approaches that employ media theory metaphors, including cinematography and photojournalism, as heuristic devices for understanding the production, transmission, and reception of ancient biblical texts. Such perspectives underscore the dynamic interaction between revelation and culture, demonstrating that enduring faith traditions depend upon intentional processes of cultural transmission that preserve theological truth while enabling adaptation to changing historical contexts. By integrating insights from anthropology, sociology, educational psychology, and biblical theology, this study contributes to contemporary discussions concerning the relationship between culture, memory, leadership, and divine revelation within Judeo-Christian history.Dr. William Anderson Gittens, Doctor of DivinityPodcast 303 Cultural Transmission, Ritual Practice, and Theological Narrative:A Multidisciplinary Literature Review and Textual Analysis of Moses and John the Beloved © 2026 ISBN 978-976-97942-0-7 Dr. William Anderson Gittens'Doctor of Divinity ,Devgro Media Arts Services Publishing®2015 In collaboration with iMovie present Podcast 303 Cultural Transmission, Ritual Practice, and Theological Narrative:A Multidisciplinary Literature Review and Textual Analysis of Moses and John the Beloved © 2026 ISBN 978-976-97942-0-7 Dr. William Anderson Gittens'Doctor of Divinity ,RECOGNITIONSAs I take a moment to reflect on my journey, I am filled with profound gratitude for the Creator's guiding hand that has led me every step of the way. Life has brought me countless blessings, and at the forefront of these blessings is the immeasurable debt of thanks I owe to my late parents, Charles and Ira Gittens. They bestowed upon me their wisdom and creative spirit, which have been a consistent source of inspiration throughout my life. Their counsel and encouragement continue to resonate within me, shaping my path and purpose. To my beloved wife, Magnola Gittens, your unwavering support has been my anchor in turbulent seas. Your love and understanding provide the strength necessary to navigate life's complexities. I am eternally grateful for your presence, which comforts and uplifts me. To my brothers—Shurland, Charles, Ricardo, and my late brothers Arnott and Stephen—as well as my sisters, Emerald, Marcella, and Cheryl, thank you for being my steadfast companions along this journey. Each of you has contributed uniquely to my narrative, reminding me of the importance of family ties in shaping who I am today. I extend my heartfelt appreciation to my cousins: Joy Mayers, Kevin and Ernest Mayers, Donna Archer, Avis Dyer, and Jackie Clarke. Your love and camaraderie have enriched my life beyond measure. To my uncles, Clifford, Leonard Mayers, David Bruce, and Collin Rock, your support has been invaluable, strengthening the bonds of our family. To my children, Laron and Lisa, grandson Elijah you are my pride and joy, the motivation behind my work, fuelling my desire to create and inspire.Moreover, I am equally grateful to all who have believed in me and wanted nothing but the best for my growth. Mr. and Mrs. Andrew Platizky, Mr. Matthew Sutton, Mr. Juan Arroyo, Mr. and Mrs. David Lavine, and many others have played pivotal roles in my development, encouraging me to pursue my passions relentlessly. During my time at New Jersey City University (NJCU), I had the privilege of receiving guidance from exceptional mentors, including the late Dr. Joseph Drew, Merline Mayers, Mrs. Ellen Gordon, Dr. Nicholas Gordon, Rev. Dr. Scofield Eversley BSS, and many others. Conversations about enhancing my writing skills after graduating were integral to my growth, providing the foundation for my future endeavours. Over the past three decades, my experiences in the leisure activities industry have significantly shaped my journey. From 1995 to 2026, I have devoted myself to writing, resulting in 476 E-Publications and 303 podcasts that resonate within the community. In recognition of the profound impact Dr. Joseph Drew had on my academic and personal development, I dedicated my 66th publication, "A Tribute to Culture" Vol. 1, to him—a small token of gratitude for his enormous influence on my life.As I look forward to what lies ahead, I remain thankful to all who have contributed to my story and to the Creator for the endless possibilities this journey holds. Each person's presence has left an indelible mark on my life, guiding me toward a future filled with hope and potential.Dr. William Anderson Gittens, D.D. ReferencesAssmann, J. (2011). Cultural memory and early civilization: Writing, remembrance, and political imagination. Cambridge University Press.Assmann, J. (2011). Cultural memory and early civilization: Writing, remembrance, and political imagination. Cambridge University Press.Bandura, A. (1977). Social learning theory. Prentice Hall.Bandura, A. (1977). Social learning theory. Prentice Hall.Bandura, A. (1977). Social learning theory. Prentice Hall.Bauckham, R. (2006). Jesus and the eyewitnesses: The Gospels as eyewitness testimony. Eerdmans.Bauckham, R. (2006). Jesus and the eyewitnesses: The Gospels as eyewitness testimony. Eerdmans.Berger, P. L., & Luckmann, T. (1966). The social construction of reality. Anchor Books.Berger, P. L., & Luckmann, T. (1966). The social construction of reality. Anchor Books.Bible Analysis. (n.d.). John the Beloved and biblical figures overview. Retrieved July 2, 2026, from https://www.bibleanalysis.orgBibles.chat. (n.d.). John the Baptist: Life and ministry overview. Retrieved July 2, 2026, from https://www.bibles.chatBourdieu, P. (1977). Outline of a theory of practice. Cambridge University Press.Brown, R. E. (1966). The Gospel according to John (I–XII). Yale University Press.Brown, R. E. (1966). The Gospel according to John (Vol. 1). Doubleday.Brueggemann, W. (1997). Theology of the Old Testament: Testimony, dispute, advocacy. Fortress Press.Brueggemann, W. (1997). Theology Support the showCultural Factors Influence Academic Achievements© 2024 ISBN978-976-97385-7-7 A_MEMOIR_OF_Dr_William_Anderson_Gittens_D_D_2024_ISBNISBN978_976_97385_0_8Academic.edu. Chief of Audio Visual Aids Officer Mr. Michael Owen Chief of Audio Visual Aids Officer Mr. Selwyn Belle Commissioner of Police Mr. Orville Durant Dr. William Anderson Gittens, D.D En.wikipedia.org/wiki/Lifelong_learning Hackett Philip Media Resource Development Officer Holder, B,Anthony Episcopal Priest,https://brainly.com/question/36353773https://en.wikipedia.org/wiki/Lifelong_learning#cite_note-19https://en.wikipedia.org/wiki/Lifelong_learning#cite_note-:2-18https://independent.academia.edu/WilliamGittens/Bookshttps://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=william+anderson+gittens+barbados&oq=william+anderson+gittenshttps://www.academia.edu/123754463/https://www.buzzsprout.com/429292/episodes. https://www.youtube.com/@williamandersongittens1714. Mr.Greene, Rupert

► Today I'm welcoming onto the Polymath PolyCast. Julie Lavergne who is a polymathic generalist, TEDx Speaker, and Host of The Generalist Advantage podcast!Kicking off season 8 strong!Links:https://8ballclarity.com/TEDxhttps://www.linkedin.com/in/julie-lavergne/Generalist Advantage PodcastMentioned:Polymathy PanelChapters00:00 From Corporate to Curiosity: A Journey of Transformation02:44 The Engineering Mindset: Problem Solving and Process05:36 The Art of Communication: Navigating Multiple Roles08:35 Curiosity as a Skill: Embracing the Unknown11:27 Travel and Growth: Expanding Horizons through Experience14:18 The Juggling Act: Balancing Multiple Interests17:12 Content Creation: The Pursuit of Passion and Challenge20:00 TEDx and Beyond: Sharing Messages and Personal Growth22:38 The Art of Conversation: Orchestrating Meaningful Dialogues27:36 Defining Polymathy: Generalist vs. Polymath30:41 Measuring Accomplishment: The Polymath's Journey32:58 The Multidisciplinary Spectrum: Understanding Expertise38:30 The Genesis of the Generalist Advantage Podcast49:25 8 Ball Clarity: Enhancing Decision-Making with AI▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬► Affiliates:Videos Repurposed with Opus Clip:https://www.opus.pro/?via=729b77Social Posts Automated with Nuelink:http://nuelink.com/?via=dustin▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬►

Rachel is joined by Jacob Boehme, an award-winning filmmaker, choreographer, and cultural leader. Jacob shares his journey from a troubled teenager in Melbourne's western suburbs to his studies, where he discovered the deep connections between traditional cultural practice and theatre. We also explore his acclaimed solo work Blood on the Dance Floor, which centres First Nations experiences of living with HIV. He closes after speaking about his current role leading the Mob+ program at Thorne Harbour Health's Positive Living Centre in Prahran. Chapters 00:00 - Show introduction and guest overview 01:52 - Early theatre and dance beginnings 05:54 - Cultural discovery and identity at NAISDA 08:22 - Multidisciplinary ceremony as theatre practice 11:45 - Founding Yirramboi Festival with self-determination 15:50 - Blood on the Dance Floor 20:21 - Introducing the Mob Plus program 26:03 - Hopes for the future of Mob+ All chapter timecodes are approximate. Want more Well Well Well? Check out our other JOY Podcasts for more on LGBTIQ+ health and wellbeing at joy.org.au/wellwellwell. If there's something you'd like us to explore on the show, send through ideas or questions at wellwellwell@joy.org.au Find out more about LGBTIQ+ services and events in Victoria and South Australia at thorneharbour.org. Produced by: Rachel Cook, Jack Crnjanin

Please visit answersincme.com/FAJ860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Nancy L. Kuntz, MD; Vanessa Battista, DNP, MBA, CPNP-PC, CHPPN, FPCN, FAAN; and Ethan Hilgert. In this activity, experts in the management of spinal muscular atrophy (SMA) discuss the diagnosis and treatment of late-onset SMA (type 3b, 4) in adults. Upon completion of this activity, participants should be better able to: Recognize clinical features that are suggestive of SMA in adults; Review the evidence for approved disease-modifying therapies in adult patients with SMA; and Apply strategies that address barriers to achieving optimal clinical outcomes in adults with SMA.

Please visit answersincme.com/MRQ860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Alexandra K. Golant, MD; Peter Lio, MD, FAAD; and Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP. In this activity, experts in dermatology discuss the OX40L pathway and its potential role in the treatment of moderate-to-severe atopic dermatitis. Upon completion of this activity, participants should be better able to: Identify the rationale for targeting the OX40/OX40 ligand (OX40L) pathway in the treatment of moderate-to-severe atopic dermatitis (AD); Assess the evidence on efficacy outcomes and safety profiles of the emerging OX40/OX40L inhibitors in AD, including quality of life (QoL) impact; Integrate QoL assessments into shared decision-making with patients who have moderate or severe AD; and Outline strategies for enhancing the multidisciplinary management of moderate-to-severe AD.

Please visit answersincme.com/MRQ860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Alexandra K. Golant, MD; Peter Lio, MD, FAAD; and Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP. In this activity, experts in dermatology discuss the OX40L pathway and its potential role in the treatment of moderate-to-severe atopic dermatitis. Upon completion of this activity, participants should be better able to: Identify the rationale for targeting the OX40/OX40 ligand (OX40L) pathway in the treatment of moderate-to-severe atopic dermatitis (AD); Assess the evidence on efficacy outcomes and safety profiles of the emerging OX40/OX40L inhibitors in AD, including quality of life (QoL) impact; Integrate QoL assessments into shared decision-making with patients who have moderate or severe AD; and Outline strategies for enhancing the multidisciplinary management of moderate-to-severe AD.

Please visit answersincme.com/MRQ860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Alexandra K. Golant, MD; Peter Lio, MD, FAAD; and Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP. In this activity, experts in dermatology discuss the OX40L pathway and its potential role in the treatment of moderate-to-severe atopic dermatitis. Upon completion of this activity, participants should be better able to: Identify the rationale for targeting the OX40/OX40 ligand (OX40L) pathway in the treatment of moderate-to-severe atopic dermatitis (AD); Assess the evidence on efficacy outcomes and safety profiles of the emerging OX40/OX40L inhibitors in AD, including quality of life (QoL) impact; Integrate QoL assessments into shared decision-making with patients who have moderate or severe AD; and Outline strategies for enhancing the multidisciplinary management of moderate-to-severe AD.

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Zarazuela Zolkipli-Cunningham, MBChB, MRCP Guest: Oscar H. (Hank) Mayer, MD Thymidine kinase 2 deficiency (TK2d) is a rare mitochondrial myopathy that can involve multiple organ systems, requiring care from different specialties. Given that need for multidisciplinary coordination, Dr. Charles Turck speaks with Drs. Hank Mayer and Zuela Zolkipli-Cunningham to learn how we can improve communication and collaboration across the care team throughout the diagnostic and management journey. Coming to us from the Children's Hospital of Philadelphia, Dr. Mayer is the Director of the Pulmonary Function Laboratory, and Dr. Zolkipli-Cunningham is the Director of Clinical Research in the Mitochondrial Medicine Frontier Program.

This episode of The Behavioral View explores collaboration between behavior analysts, school psychologists, special education teachers, and other professionals serving students across educational and clinical settings. The panel discusses practical strategies for building rapport with school teams, coordinating assessment and intervention efforts, and aligning goals across disciplines to improve learner outcomes. To earn CEUs for listening, click here, log in or sign up, pay the CEU fee, + take the attendance verification quiz to generate your certificate! Don't forget to subscribe and follow and leave us a rating and review. Show Notes: References Snyder SM, Huber H, Hornsby T, Leventhal B. (2024). Overlapping Training and Roles: An Exploration of the State of Interprofessional Practice between Behavior Analysts and School Psychologists. Behavior Analysis in Practice, 17(3):880-892. doi: 10.1007/s40617-023-00904-y Baer, D. M., Wolf, M. M., & Risley, T. R. (1968). Some current dimensions of applied behavior analysis. Journal of Applied Behavior Analysis, 1(1), 91–97. Cooper, J. O., Heron, T. E., & Heward, W. L. (2020). Applied behavior analysis (3rd ed.). Pearson. Resources CentralReach Institute: https://centralreach.com CR Assessments (ABLLS-R, AFLS, AIM): https://centralreach.com National Association of School Psychologists (NASP): https://www.nasponline.org The Behavioral View Podcast School-Wide Positive Behavioral Interventions and Supports (PBIS): https://www.pbis.org Multi-Tiered System of Supports (MTSS) Center

Welcome to Art is Awesome, the show where we talk with an artist or art worker with a connection to the San Francisco Bay Area.  This week, Emily Wilson sits down with Julia Goodman, a San Francisco-based artist who makes paper and textiles, as well as paintings and sculptures. They meet on the campus of the California College of the Arts — the last art school in San Francisco, set to close at the end of the 2026–27 school year — where Julia has been teaching. Their conversation covers Julia's winding path to art, the meditative and cathartic labor of making paper from recycled fabrics, grief, and an ongoing audio archive project about astronomy and motherhood. About Artist Julia Goodman: Julia Goodman is an artist and educator working at the intersection of papermaking, textiles, sculpture, and painting. Her work is held in the collections of the National Museum of Women in the Arts (NMWA), DePaul Art Museum, Recology San Francisco, and Google. Unimaginable Units of Time marks her first solo museum exhibition, presented at the San Luis Obispo Museum of Art. Recent group exhibitions include NMWA, Contemporary Jewish Museum, San Jose Museum of Art, DePaul Art Museum, Poetry Foundation, and Berkeley Art Center. Her residencies include JB Blunk Residency, Recology SF, Creativity Explored, Salina Art Center, The Space Program SF, and The Eames Institute. She is a recipient of the 2020 Women to Watch Award from the San Francisco chapter of NMWA. She is a longtime resident of the San Francisco Bay Area and started making paper in 2003 with a kitchen blender and old window screens. Visit Julia's  Website:  JAGoodman.com Follow Julia on Instagram:  @JuliaAnneGoodman Learn more about Julia's Wrenching News Workshops HERE. -- About Podcast Host Emily Wilson: Emily a writer in San Francisco, with work in outlets including Hyperallergic, Artforum, 48 Hills, the Daily Beast, California Magazine, Latino USA, and Women's Media Center. She often writes about the arts. For years, she taught adults getting their high school diplomas at City College of San Francisco. Follow Emily on Instagram: @PureEWil Follow Art Is Awesome on Instagram: @ArtIsAwesome_Podcast -- CREDITS: Art Is Awesome is Hosted, Created & Executive Produced by Emily Wilson.  Theme Music "Loopster" Courtesy of Kevin MacLeod (incompetech.com)Licensed under Creative Commons: By Attribution 4.0 License The Podcast is Co-Produced, Developed & Edited by Charlene Goto of @GoToProductions.  For more info, visit Go-ToProductions.com Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Please visit answersincme.com/860/IME_2025_00013162-replay to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Toby Maher, MB, MSc, PhD, FRCP; and Justin Oldham, MD, MS. In this activity, experts explore advances in ILD care, including personalized, multidisciplinary approaches to integrate novel antifibrotic therapy and enhance patient engagement. Upon completion of this activity, participants should be better able to: Recognize the rationale for novel antifibrotic therapy in interstitial lung disease (ILD); Apply the latest clinical data on novel antifibrotic therapy to therapeutic decision-making in ILD; and Outline multidisciplinary strategies to enhance the care of patients with ILD who are receiving antifibrotic therapies.

This episode of Lung Cancer Considered provide a preview of the upcoming IASLC 2026 World Conference on Lung Cancer in Seoul, South Korea this September. Key topics covered include WCLC26 highlights - Multidisciplinary, WCLC26 deadlines and information about Seoul. Guests: Myung-Ju Ahn, MD, PhD Distinguished Professor Section of Hematology-Oncology, Department of Medicine Hanyang University Medical Center, Hanyang University School of Medicine Seoul, Republic of Korea Vincent Wentao Fang, MD Professor, Department of Thoracic Surgery Shanghai East Hospital Tongji University Medical School Jiraporn Setakornnukul, MD, PhD Radiation Oncologist, Associate Professor Division of Radiation Oncology Department of Radiology Faculty of Medicine, Siriraj Hospital Mahidol University Bangkok, Thailand Yasushi Yatabe, MD, PhD Chief, Department of Diagnostic Pathology, National Cancer Center Hospital Chief, Division of Molecular Pathology, National Cancer Center Research Institute National Cancer Center Japan

In this episode of Better Edge, Transplant Hepatologist Laura Lulik, MD moderates a panel discussion about the Northwestern Medicine Liver Transplant Tumor Clinic. The conversation covers advances in imaging, systemic therapies and innovative procedures, as well as the clinic's multidisciplinary approach.The panel includes: • Daniel Borja, MD, transplant surgeon• Aparna Kalyan, MD, medical oncologist • Robert Lewandowski, MD, interventional radiologist• Amira Borhani, MD, abdominal radiologist

Multidisciplinary astrophysicist, inventor, award-winning author, and journalist Hakeem Oluseyi joins Tavis in studio to discuss his newest book, “Why Do We Exist? The Nine Realms Of The Universe That Make You Possible,” and more.Become a supporter of this podcast: https://www.spreaker.com/podcast/tavis-smiley--6286410/support.

CardioNerds (Dr. Billy-Joe Mullinax, Dr. Dinu Balanescu, and Dr. Jane Ehret) discuss risk stratification in acute pulmonary embolism with Dr. Stavros Konstantinides, Chair of the 2019 ESC Pulmonary Embolism Guidelines. Using a real-world case, this episode explores how modern PE care has moved beyond “massive” and “submassive” labels toward a dynamic, physiology-based approach. The discussion highlights the limitations of static risk scores, the importance of right ventricular dysfunction and biomarkers, and why normotension does not imply stability. Special emphasis is placed on intermediate-high risk PE, early identification of impending hemodynamic collapse, and the role of lactate, serial reassessment, and PERT teams in guiding escalation of care. Audio editing by CardioNerds intern, Joshua Khorsandi.The 2026 American multi-society PE guidelines were published after this episode was recorded. Dr. Dinu Balanescu and Dr. Billy-Joe Mullinax are Co-chairs for the CardioNerds PE Series, developed in collaboration with the PERT Consortium.   Enjoy this Circulation 2022 Paths to Discovery article to learn about the CardioNerds story, mission, and values. CardioNerds Pulmonary Embolism PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron! Pearls Stable blood pressure does not mean low risk in PEHypotension is a late finding. Patients may have severe RV failure, hypoxia, and tissue hypoperfusion while remaining normotensive — a key concept behind “normotensive shock.” Risk stratification in PE must be dynamic, not staticLegacy scores like PESI and Bova provide a snapshot and predict 30-day mortality, but they do not capture short-term trajectory or impending hemodynamic collapse. Intermediate-high risk PE is a dangerous and heterogeneous groupPatients with RV dysfunction, positive biomarkers, tachycardia, hypoxemia, and elevated lactate may have in-hospital mortality approaching 15%, rivaling STEMI. Lactate is a critical but underutilized marker in PEElevated lactate reflects tissue hypoxia and early circulatory failure and may identify patients at risk for collapse before blood pressure declines. PERT enables physiology-driven, patient-centered PE carePERT teams operationalize continuous reassessment, integrate imaging, labs, and clinical trajectory, and allow timely escalation — shifting PE management from rigid categories to real-time decision-making. Notes Drafted by Dr. Jane Ehret. 1. What is the contemporary framework for risk stratification in acute pulmonary embolism? Modern PE risk stratification prioritizes hemodynamics and right ventricular (RV) function rather than clot burden. The 2019 ESC Guidelines classify PE into high risk, intermediate risk (low vs high), and low risk, based on: Hemodynamic status, RV dysfunction on imaging, and Cardiac biomarkers. This framework emphasizes early mortality risk but requires clinical context to guide escalation decisions. 2. Why is normotension insufficient to define “stability” in PE? Blood pressure is a late marker of circulatory failure in PE. Patients can maintain normal BP through Tachycardia, Increased sympathetic tone, and RV compensation. Many patients with preserved BP may already have shock physiology, including hypoxemia, elevated lactate, and RV failure — sometimes referred to as “normotensive shock.” 3. How should intermediate-risk PE be conceptualized clinically? Intermediate-risk PE is heterogeneous, ranging from patients who do well on anticoagulation to those who deteriorate rapidly. Intermediate-high risk PE is defined by RV dysfunction on imaging and positive cardiac biomarkers. Clinical features such as tachycardia, increasing oxygen requirement, and elevated lactate identify patients at highest risk within this group. 4. What are the strengths and limitations of commonly used PE risk scores? Legacy scores are useful for initial risk categorization but are static and limited in predicting short-term deterioration. Most scores were developed to predict mortality or complications at fixed time points rather than dynamic clinical trajectory. 5. What are the commonly used risk scores and clinical tools in PE, and what is each designed to predict? ESC Risk Stratification Algorithm: Identifies high-risk PE by hemodynamics. Uses PESI or sPESI in normotensive patients to distinguish low-risk from non–low-risk PE. Uses RV dysfunction and biomarkers to differentiate intermediate-low from intermediate-high risk. Forms the basis of many institutional PE pathways. PESI and sPESI: Validated to predict 30-day mortality. Widely used to identify low-risk patients appropriate for outpatient management. Heavily influenced by age and comorbidities. Bova Score: Predicts 30-day PE-related complications in normotensive patients. Composite PE Shock Score (CPES): Predicts normotensive shock in hemodynamically stable PE patients. Pulmonary Embolism Progression (PEP) Score: Predicts progression from intermediate-risk to high-risk PE within 72 hours of diagnosis. PE Short-term Clinical Outcomes Risk Estimation (PE-SCORE): Predicts clinical deterioration or death within 5 days of PE diagnosis. Hestia Criteria: Identifies low-risk PE patients safe for outpatient treatment. Wells' Criteria and Revised Geneva Score: Determine pretest probability for diagnostic triage. PERC Score: Rules out PE in very low-risk patients. 6. What is the role of biomarkers in PE risk stratification? Troponin and natriuretic peptides reflect RV myocardial injury and strain. Current guidelines treat biomarkers as binary (positive vs negative), despite risk being continuous. Biomarkers are most helpful for: Initial risk classification. They are less useful for: Short-interval monitoring and Detecting rapid clinical deterioration. 7. Why is lactate an important physiologic marker in PE? Lactate reflects global tissue hypoxia and impaired perfusion. Elevated lactate may identify patients with: Early circulatory failure and Increased risk of imminent hemodynamic collapse. Lactate is not currently included in ESC risk algorithms but may add important prognostic information in intermediate-risk patients. 8. How does trajectory influence decision-making in PE management? Risk stratification should be viewed as a dynamic process, not a one-time label. Worsening clinical trajectory may include: Rising heart rate, Increasing oxygen needs, Rising lactate, and Progressive RV dysfunction. Serial reassessment is essential for timely escalation of care. 9. What role do Pulmonary Embolism Response Teams (PERT) play in risk stratification? PERT facilitates: Multidisciplinary decision-making and Integration of imaging, biomarkers, and clinical physiology. PERT is most valuable for: Intermediate-risk and high-risk PE and Patients with complex comorbidities or uncertain trajectory. PERT enables a shift from category-based to physiology-driven PE care. References 1. Konstantinides SV, Meyer G, Becattini C, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). Eur Respir J. 2019;54(3):1901647. Published 2019 Oct 9. doi:10.1183/13993003.01647-2019 2. Leidi A, Bex S, Righini M, Berner A, Grosgurin O, Marti C. Risk Stratification in Patients with Acute Pulmonary Embolism: Current Evidence and Perspectives. J Clin Med. 2022;11(9):2533. Published 2022 Apr 30. doi:10.3390/jcm11092533 3. Choi WH, Kwon SU, Jwa YJ, et al. The pulmonary embolism severity index in predicting the prognosis of patients with pulmonary embolism. Korean J Intern Med. 2009;24(2):123-127. doi:10.3904/kjim.2009.24.2.123 4. Jiménez D, Aujesky D, Moores L, et al. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med. 2010;170(15):1383-1389. doi:10.1001/archinternmed.2010.199 5. Chen X, Shao X, Zhang Y, et al. Assessment of the Bova score for risk stratification of acute normotensive pulmonary embolism: A systematic review and meta-analysis. Thromb Res. 2020;193:99-106. doi:10.1016/j.thromres.2020.05.047 6. Zhang RS, Yuriditsky E, Zhang P, et al. Composite Pulmonary Embolism Shock Score and Risk of Adverse Outcomes in Patients With Pulmonary Embolism. Circ Cardiovasc Interv. 2024;17(8):e014088. doi:10.1161/CIRCINTERVENTIONS.124.014088 7. Zhang RS, Alam U, Sharp ASP, et al. Validating the Composite Pulmonary Embolism Shock Score for Predicting Normotensive Shock in Intermediate-Risk Pulmonary Embolism. Circ Cardiovasc Interv. 2024;17(2):e013399. doi:10.1161/CIRCINTERVENTIONS.123.013399 8. Ehret J, Wakefield D, Badlam J, Antkowiak M, Erdreich B. Development of the Pulmonary Embolism Progression (PEP) score for predicting short-term clinical deterioration in intermediate-risk pulmonary embolism: a single-center retrospective study. J Thromb Thrombolysis. 2025;58(2):243-253. doi:10.1007/s11239-024-03051-5 9. Weekes AJ, Raper JD, Lupez K, et al. Development and validation of a prognostic tool: Pulmonary embolism short-term clinical outcomes risk estimation (PE-SCORE). PLoS One. 2021;16(11):e0260036. Published 2021 Nov 18. doi:10.1371/journal.pone.0260036 10. Zondag W, Hiddinga BI, Crobach MJ, et al. Hestia criteria can discriminate high- from low-risk patients with pulmonary embolism. Eur Respir J. 2013;41(3):588-592. doi:10.1183/09031936.00030412 11. Wells PS, Anderson DR, Rodger M, et al. Excluding pulmonary embolism at the bedside without diagnostic imaging: management of patients with suspected pulmonary embolism presenting to the emergency department by using a simple clinical model and d-dimer. Ann Intern Med. 2001;135(2):98-107. doi:10.7326/0003-4819-135-2-200107170-00010 12. Wolf SJ, McCubbin TR, Feldhaus KM, Faragher JP, Adcock DM. Prospective validation of Wells Criteria in the evaluation of patients with suspected pulmonary embolism. Ann Emerg Med. 2004;44(5):503-510. doi:10.1016/j.annemergmed.2004.04.002 13. Le Gal G, Righini M, Roy PM, et al. Prediction of pulmonary embolism in the emergency department: the revised Geneva score. Ann Intern Med. 2006;144(3):165-171. doi:10.7326/0003-4819-144-3-200602070-00004 14. Kline JA, Mitchell AM, Kabrhel C, Richman PB, Courtney DM. Clinical criteria to prevent unnecessary diagnostic testing in emergency department patients with suspected pulmonary embolism. J Thromb Haemost. 2004;2(8):1247-1255. doi:10.1111/j.1538-7836.2004.00790.x 15. Kline JA, Courtney DM, Kabrhel C, et al. Prospective multicenter evaluation of the pulmonary embolism rule-out criteria. J Thromb Haemost. 2008;6(5):772-780. doi:10.1111/j.1538-7836.2008.02944.x

In this episode of Precision and Progress: Radiotherapy in Oncology, hosts Hirsch Matani, MD, and Elizabeth Zhang-Velten, MD, PhD, welcomed Binh T. Ngo, MD, to discuss the evolving role of radiation, systemic therapy, and multidisciplinary care for patients with melanoma and other skin cancers.Dr Matani is a clinical assistant professor of radiation oncology at the Keck School of Medicine of the University of Southern California (USC) and a radiation oncologist at the USC Norris Comprehensive Cancer Center. Dr Zhang-Velten is a radiation oncologist and a clinical assistant professor with Keck Medicine of USC. Dr Ngo is an assistant professor of dermatology at Keck Medicine of USC.In their discussion, Drs Matani, Zhang-Velten, and Ngo broke down how surgical approaches, radiation, and systemic therapy all play roles in the treatment of patients with skin cancer. Dr Ngo highlighted key prevention strategies that patients should be advised on, along with recommended follow-ups for patients who are at higher risk or those who underwent prior solid organ or hematologic transplants.The trio also discussed how the use of radiation for patients with skin cancer varies from techniques used for patients with tumors located within deeper organs, and they also highlighted how radiotherapy approaches could be applied for patients with tumors that would be difficult to surgically resect.

Niyi Adeogun is a multidisciplinary artist, creative director, and founder of CXRE Labs, a creative studio exploring the intersection of art, design, and technology. His work spans visual art, brand identity, immersive experiences, and experimental design, often using symbolism and storytelling to create pieces that feel both personal and thought-provoking.Originally from Lagos, Nigeria, and now based in Canada, Niyi's practice is rooted in curiosity, emotion, and innovation. He is passionate about creating work that not only looks compelling but also invites deeper reflection on identity, connection, faith, and the human experience.Through his studio and personal practice, Niyi continues to build projects that blur the lines between disciplines, bringing together art, design, and emerging technology in ways that feel meaningful, accessible, and alive.Check him out @niyiadeogun

CME credits: 0.25 Valid until: 01-06-2027 Claim your CME credit at https://reachmd.com/programs/cme/chairpersons-perspective-reframing-first-line-and-subsequent-care-in-advanced-urothelial-carcinoma-clinical-implications-of-the-updated-nccn-guidelines/54396/ This 15-minute online CME activity reviews the clinical implications of the updated NCCN Guidelines for advanced urothelial carcinoma (aUC), with a focus on evolving first-line and subsequent treatment strategies. The program highlights the shift away from cisplatin eligibility as the primary determinant of frontline therapy selection and examines key clinical trial data that inform current practice. Participants will explore sequencing considerations following frontline therapy as well as the role of biomarker-directed therapies in later lines of care. The activity also emphasizes early recognition and management of treatment-related adverse events alongside strategies for dose modification and supportive care. Multidisciplinary coordination and shared decision-making are discussed as essential components of optimizing patient-centered care in aUC.=

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PGK865. CME/AAPA/IPCE credit will be available until May 20, 2027.Propelling Modern Interventions in Neuroendocrine Carcinoma: Multidisciplinary Principles to Effectively Implement Emerging DLL3-Directed BiTE Therapy in Community Settings In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

View the full article at: https://oncdata.com/oncology-unfiltered-tumor-board-vs-tuesday-afternoon Tumor boards play a pivotal role in oncology care. For clinicians, they represent the ideal environment: multiple specialists, shared context, and time to debate the gray areas that guidelines can't fully capture. However, during a busy afternoon in the clinic, the plans developed in tumor boards often prove less straightforward to implement. In this episode of Oncology Unfiltered, Melissa Cutrona, MS, and Matthew Hadfield, DO, OncData Editor in Chief, unpack why tumor boards are so valuable, where they fall short, and how to bridge the gap between a coordinated plan and the reality of care delivery on a busy clinic day.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PGK865. CME/AAPA/IPCE credit will be available until May 20, 2027.Propelling Modern Interventions in Neuroendocrine Carcinoma: Multidisciplinary Principles to Effectively Implement Emerging DLL3-Directed BiTE Therapy in Community Settings In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PGK865. CME/AAPA/IPCE credit will be available until May 20, 2027.Propelling Modern Interventions in Neuroendocrine Carcinoma: Multidisciplinary Principles to Effectively Implement Emerging DLL3-Directed BiTE Therapy in Community Settings In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PGK865. CME/AAPA/IPCE credit will be available until May 20, 2027.Propelling Modern Interventions in Neuroendocrine Carcinoma: Multidisciplinary Principles to Effectively Implement Emerging DLL3-Directed BiTE Therapy in Community Settings In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PGK865. CME/AAPA/IPCE credit will be available until May 20, 2027.Propelling Modern Interventions in Neuroendocrine Carcinoma: Multidisciplinary Principles to Effectively Implement Emerging DLL3-Directed BiTE Therapy in Community Settings In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PGK865. CME/AAPA/IPCE credit will be available until May 20, 2027.Propelling Modern Interventions in Neuroendocrine Carcinoma: Multidisciplinary Principles to Effectively Implement Emerging DLL3-Directed BiTE Therapy in Community Settings In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

CME credits: 0.50 Valid until: 29-05-2027 Claim your CME credit at https://reachmd.com/programs/cme/all-hands-on-deck-multidisciplinary-coordination-for-smarter-perioperative-care/57093/ This online CME activity uses a patient–clinician dialogue format to explore the evolving role of perioperative immunotherapy in locally advanced head and neck squamous cell carcinoma (HNSCC). Expert commentary and patient-centered discussions address how to identify appropriate candidates based on disease stage, PD-L1 expression, resectability, and overall fitness for multimodality therapy. The program reviews clinical evidence from perioperative studies, with emphasis on implications for integrating immunotherapy into curative-intent care. Practical considerations include surgical timing, multidisciplinary coordination, and management of immune-related adverse events. By illustrating shared decision-making and real-world communication between clinicians and patients, this program offers actionable insights into aligning treatment with patient goals while optimizing care across the perioperative continuum.

In today's episode, we spoke with Anthony Chi, MD, a staff pathologist; Monica Peravali, MD, a medical oncologist; and Archana Jadhav, MD, a medical oncologist, all faculty at the Mid-Atlantic Permanente Medical Group in Maryland. In our exclusive interview, Drs Chi, Peravali, and Jadhav discussed the practical advantages and clinical implications of implementing in-house next-generation sequencing (NGS) testing for patients with non–small cell lung cancer (NSCLC). The conversation focused on how internal molecular testing platforms can improve turnaround times, optimize tissue stewardship, reduce costs, and enhance quality control across the diagnostic and treatment continuums.Chi explained that performing NGS internally eliminates delays associated with specimen transportation and external laboratory accessioning, significantly shortening turnaround times. He also highlighted Kaiser Permanente's decision to implement a molecular platform distinct from those commonly used by outside vendors, allowing for reduced tissue input requirements and faster processing times. According to Chi, internal testing also gives pathology teams greater oversight of specimen use, enabling more strategic tissue conservation for future immunohistochemical (IHC) staining, repeat molecular analyses, or additional biomarker testing.The panel emphasized the importance of close coordination between pathology and oncology teams in maximizing tissue adequacy, particularly in small biopsies and cytology specimens. Chi described educational initiatives implemented within pathology departments to encourage judicious use of IHC stains and preserve tissue for downstream molecular testing. He also outlined specimen-handling workflows in which tissue is divided into separate cassettes to prioritize molecular analysis and still supporting diagnostic evaluation.Jadhav discussed the oncologist's role in ensuring adequate tissue acquisition, emphasizing proactive communication with pathologists and interventional radiologists. She noted that when clinicians anticipate limited tissue yield, such as in pleural fluid cytology specimens, they often promptly arrange additional biopsies to avoid delays in treatment initiation and ensure comprehensive genomic profiling can be completed efficiently.The discussion also addressed optimal timing for comprehensive genomic profiling in NSCLC. Peravali explained that Kaiser Permanente routinely performs NGS across all disease stages, including early-stage disease, due to increasing use of neoadjuvant chemoimmunotherapy approaches and the need to identify actionable biomarkers that may influence treatment selection. Although in-house testing serves as the primary platform, she noted that send-out testing remains important in select situations, including cancers of unknown primary origin, clinical trial enrollment, and discordant or clinically suspicious cases requiring additional confirmation.As molecular reports become increasingly complex, the panel highlighted the importance of interpreting co-mutations, variants of unknown significance, and emerging biomarkers within a broader clinical context. Peravali explained that although variants without current therapeutic relevance may not immediately affect treatment decisions, repeat biopsies and serial NGS at disease progression can reveal newly actionable alterations as therapeutic options evolve.Chi further emphasized the growing importance of newly approved biomarkers, including HER2 and c-MET alterations, in NSCLC. He described how pathology teams actively monitor FDA approvals and National Comprehensive Cancer Network (NCCN) guideline updates to identify new therapeutic opportunities for previously profiled patients. In some cases, archived tumor specimens are revisited for additional IHC testing when emerging therapies become clinically relevant.The conversation also highlighted the value of multidisciplinary collaboration and tumor board discussions in complex diagnostic scenarios. The speakers described how integrated molecular analysis can help distinguish separate primary lung tumors from metastatic disease, resolve diagnostically challenging cases involving uncommon metastatic presentations, and support more confident staging and treatment decisions.Finally, the panel underscored that successful implementation of precision oncology workflows depends on seamless collaboration among pulmonologists, pathologists, oncologists, interventional radiologists, and molecular laboratories. Early test ordering, centralized communication systems, and multidisciplinary case review were identified as key components of efficient, patient-centered care that can accelerate diagnosis and improve treatment planning for patients with lung cancer.

In this episode of Head and Neck Innovations, Edward Doyle, MD, and Varun Kshettry, MD, join host Paul Bryson, MD, to discuss the diagnosis and management of cerebrospinal fluid (CSF) leaks and encephaloceles. They explore common presentations, advances in imaging and diagnostic testing, and collaborative surgical approaches for skull base repair. The conversation also highlights the growing recognition of idiopathic intracranial hypertension as an underlying cause of spontaneous CSF leaks, as well as emerging treatment strategies including venous sinus stenting, weight management, and GLP-1 receptor agonists.

Multidisciplinary musician and video game composer Floor Baba was the focus of "Hot Takes" episode 100! After a prolonged period of not having Quiz on the show as co-host, we finally got him back and with a terrific pull too! Known for their work on the soundtracks for Pac Man: Snack Break and Egg Squeeze, their affiliation with the Pluswav Cooperative, and their wonky, futuristic take on vapor-adjacent experimental electronic music; two hours was seemingly only enough to scratch the surface of Jesse's experience, as we heard their history and fielded questions from the live chat as well. We conversed about 90's and 2000's Christian music and what it's like to compose soundtracks for video games. A lot of talk about how much cratedigging transpires daily and how Floor Baba likes to listen to music took place. Other topics that came up in conversation include the stories behind some of Jesse's album artwork, the psychological horror of playing Egg Squeeze,  their favorite composers, starting a label, and their favorite N64 OST's. The memorable moments we got to spend with Floor Baba that night cannot be quantified, so what are you waiting for? Hit play!   "Hot Takes" is a safe space for all opinions! Join the conversation at https://linktr.ee/hottakesvapor

Multidisciplinary artist Maxi Glamour has shared their storytelling prowess through songwriting, drag and queer-friendly events by way of their Faeded series. Recently, they have completed “Faeded: The Opera” which premieres June 5 at the Contemporary Art Museum in partnership with the Pulitzer Arts Foundation. Glamour gives us a peek into their motivations to write their first opera, the evolution of Faeded over the years and their take on how “queerness” transcends sexual orientation.

In this episode, Ronjon Paul, MD, Orthopedic Spine Surgeon, Endeavor Health Medical Group, discusses developing multidisciplinary spine programs, leading within a large health system, and how AI is transforming patient care, clinical decision making, and physician workflows.

In this episode, CardioNerds Dr. Colin Blumenthal, Dr. Kelly Arps, and Dr. Yong Hao Yeo are joined by electrophysiology expert Dr. Bradley Knight to discuss atrial fibrillation (AF) management in challenging clinical scenarios. We explore arrhythmias in patients with pre-excitation syndromes, particularly Wolff-Parkinson-White (WPW) syndrome, and strategies for rhythm control. We also discuss AF management in pregnancy, adult congenital heart disease, and patients with tachycardia-bradycardia (tach-brady) syndrome. This episode provides essential insights into nuanced decision-making for the care of patients with complex arrhythmia profiles. Audio editing by CardioNerds academy intern, Grace Qiu. Enjoy this Circulation 2022 Paths to Discovery article to learn about the CardioNerds story, mission, and values. CardioNerds Atrial Fibrillation PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron! PEARLS AF in WPW is a true emergency—AV nodal blocking agents can be deadly. In patients with WPW syndrome, AF can rapidly conduct through the accessory pathway, risking ventricular fibrillation and sudden death. Avoid AV nodal blockers like beta-blockers and calcium channel blockers. Catheter ablation is the first-line rhythm control strategy in WPW. Catheter ablation carries a Class I recommendation and offers >90% success. If antiarrhythmic drugs are needed, sodium channel blockers like flecainide or propafenone are preferred in patients without structural heart disease. In pregnancy, protecting the mother is protecting the fetus. An unstable mother means an unstable fetus. Rate control is the first step in AF with rapid ventricular responses and electrical cardioversion is safe when needed. Multidisciplinary care is essential. AF in congenital heart disease is often outside the pulmonary veins. Surgical scars and chamber remodeling in ACHD patients often lead to AF from non-pulmonary vein foci. Electrogram-based mapping and targeted ablation strategies are essential to increase success rate of durable rhythm control. Tachy-brady syndrome may require pacing to unlock therapy. AF may cause atrial myopathy and sinus node dysfunction. These patients often require permanent pacing to allow safe use of rate-controlling medications like beta-blockers and to prevent syncope or chronotropic incompetence. Notes: Notes drafted by Dr. Yong Hao Yeo Why is atrial tachycardia in patients with WPW syndrome dangerous? Patients with WPW commonly present with supraventricular tachycardia (SVT) due to atrioventricular reentrant circuits, either orthodromic or antidromic. This SVT can degenerate into AF. In the absence of AV nodal as the governor between the atrium and ventricles, the accessory pathway may conduct impulses rapidly and frequently. This can lead to dangerously high ventricular rates, predisposing patients to ventricular fibrillation and sudden cardiac arrest. What are some strategies for rhythm control in patients with WPW and atrial tachycardia? Catheter ablation is the first-line therapy (Class I recommendation), with a success rate of over 90%. Ablation reduces the risk of sudden cardiac arrest, though some patients may remain prone to AF. If ablation is not feasible/ contraindicated, sodium channel blockers such as flecainide and propafenone are good options in patients without ischemia or structural heart disease (Class IIa recommendation). Amiodarone should be avoided because it has a long half-life, can accumulate in the system, and may delay definitive treatment with catheter ablation. AV nodal blocking agents like beta blockers and calcium channel blockers should be avoided, as they are less effective at controlling ventricular rate in WPW and can increase conduction over the accessory pathway. These agents can also exacerbate the risk of rapid ventricular rates during AF and worsen left ventricular function. What are some special considerations in managing AF in pregnant patients? The primary goal in managing cardiovascular disease during pregnancy is to protect the mother, as fetal outcomes depend on maternal well-being. Therefore, while caution is necessary, we should avoid undertreating pregnant patients with AF. In cases of AF with rapid ventricular response (RVR), rate control is usually the first-line strategy, with beta blockers preferred over digoxin or non-dihydropyridine calcium channel blockers. It is then reasonable to initially observe for spontaneous conversion in stable patients. Antiarrhythmic drugs (AADs) are generally avoided during the first trimester, but clinical judgment on a case-by-case basis is essential. Evidence for the safety of AADs in pregnancy is limited, often derived from their use in other conditions such as fetal SVT. Flecainide and sotalol are reasonable options for rhythm control (Class IIa recommendation). Electrical cardioversion is considered safe in pregnancy and should be utilized when indicated (Do not forget!). There is no pregnancy-specific thromboembolic risk stratification tool. CHA₂DS₂-VASc scoring and the presence of risk factors like mitral stenosis can help guide anticoagulation decisions, though the magnitude of thromboembolic risk during pregnancy remains unclear. Rate control agents are typically continued during delivery due to the increased physiologic stress of labor and delivery. Multidisciplinary care is crucial and should involve obstetrics, maternal-fetal medicine, cardiology, and electrophysiology specialists. What are some key considerations for AF management in patients with adult congenital heart disease (ACHD)? Patients with repaired congenital heart disease are at increased risk for arrhythmias due to two main factors: surgical scars that create arrhythmogenic foci and mechanical remodeling of the atria or ventricles resulting from the underlying disease. In these patients with structural heart disease, sodium channel blockers may not be ideal antiarrhythmic options. When selecting an antiarrhythmic drug, clinicians must consider the nature of structural or surgical impairments, such as right bundle branch block or prolonged QT interval. It is also essential to assess renal and hepatic function (often impaired in patients with ACHD) to ensure appropriate metabolism and clearance of antiarrhythmic medications. Electrogram-based ablation strategies (those leveraging artificial intelligence are developing!) may help identify effective ablation targets, which are often outside the pulmonary veins in patients with ACHD. These individualized approaches can improve ablation success rates in this complex patient population. What makes tachycardia-bradycardia (tach-brady) syndrome a unique challenge in arrhythmia management? Patients who present with both AF and bradycardia, especially with syncope, require a thoughtful diagnostic approach to identify the underlying rhythm disturbance. Extended cardiac monitoring, including event monitors or implantable loop recorders, can help capture intermittent arrhythmias and correlate them with symptoms. AF may lead to atrial myopathy, and since the sinus node resides within the atrium, this can result in sinus node dysfunction—a hallmark of tachy-brady syndrome. Following spontaneous conversion from AF to sinus rhythm, sinus node dysfunction may persist, leading to prolonged pauses or chronotropic incompetence. Management becomes more complex when beta-blockers are needed for AF with RVR, as they can exacerbate bradycardia. Permanent pacemaker implantation is often the next step to consider. Permanent pacemaker implantation is often considered to facilitate safe rate control in these cases. In younger patients, aggressive AF burden reduction may prevent atrial remodeling and the development of true atrial myopathy, potentially avoiding pacemaker implantation. References Joglar JA, Chung MK, Armbruster AL, et al. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2023;149(1). doi:https://doi.org/10.1161/CIR.0000000000001193 ‌ Van IC, Rienstra M, Bunting KV, et al. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). European Heart Journal. 2024;45(36). doi:https://doi.org/10.1093/eurheartj/ehae176 ‌ Joglar JA, Kapa S, Saarel EV, et al. 2023 HRS expert consensus statement on the management of arrhythmias during pregnancy. Heart Rhythm. Published online May 1, 2023. doi:https://doi.org/10.1016/j.hrthm.2023.05.017 ‌ Stout KK, Daniels CJ, Aboulhosn JA, et al. 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: Executive Summary. Journal of the American College of Cardiology. 2019;73(12):1494-1563. doi:https://doi.org/10.1016/j.jacc.2018.08.1028 ‌

They explain how occupational therapists, physical therapists, mental health professionals, pharmacists, and others can help you manage fatigue, pain, anxiety, daily routines, and life after diagnosis, while also sharing practical tips for advocating for referrals and support.  Episode at a glance: Why autoimmune arthritis care involves more than a rheumatologist and medications The surprising evidence behind occupational therapy (OT), physical therapy, and mental health support How OT can help with fatigue, pacing, daily routines, parenting, work, and mental health, not just hand pain Why anxiety, grief, and depression are common after diagnosis, and why getting support early matters Real-life strategies for managing fatigue and adapting daily tasks without “giving up” The hidden barriers that prevent patients from accessing multidisciplinary care Tips for advocating for referrals and building a supportive care team Cheryl and Eileen's personal experiences navigating rheumatoid arthritis, fatigue, anxiety, and self-management   Medical disclaimer:  All content found on Arthritis Life public channels (including Rheumer Has It) was created for generalized informational purposes only. The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Episode Sponsors Rheum to THRIVE,  an online course and support program Cheryl created to help people with rheumatic disease go from overwhelmed, confused and alone to confident, supported and connected.  See all the details  and join the program or waitlist now! Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Ronjon Paul, MD, Orthopedic Spine Surgeon, Endeavor Health Medical Group, discusses developing multidisciplinary spine programs, leading within a large health system, and how AI is transforming patient care, clinical decision making, and physician workflows.

In this episode, Ronjon Paul, MD, Orthopedic Spine Surgeon, Endeavor Health Medical Group, discusses developing multidisciplinary spine programs, leading within a large health system, and how AI is transforming patient care, clinical decision making, and physician workflows.

Please visit answersincme.com/860/101385133-replay to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Peter A. Fasching, MD; Michael Gnant, MD, FACS; and Cristina Saura Manich, MD, PhD. In this activity, experts in breast cancer discuss new evidence in neoadjuvant and adjuvant care of early disease. Upon completion of this activity, participants should be better able to: Describe multidisciplinary viewpoints on the role that HER2-directed ADCs may play in the (neo)adjuvant setting for HER2-positive early-stage breast cancer; Evaluate evidence for the (neo)adjuvant use of HER2-directed ADCs in the multidisciplinary management of HER2-positive early-stage breast cancer; and Formulate evidence-based multidisciplinary strategies to optimally incorporate (neo)adjuvant HER2-directed ADCs into the treatment paradigm for HER2-positive early-stage breast cancer.

Professor Tara Renton OBE brings four generations of dental history — and a career built on curiosity rather than ambition — to her conversation with Payman. From navigating undiagnosed dyslexia and a father who begged her not to follow him into dentistry, to becoming the first female chair of oral surgery at King's College London, her story is one of serendipity, resilience, and an almost obsessive interest in the patient behind the pain. She shares remarkable insights into orofacial pain — nerve injuries, psychosocial histories, patients whose chronic pain only begins to shift when someone finally takes the time to ask the right question — and makes a compelling case for multidisciplinary thinking in a profession she feels has been far too siloed for far too long. Sharp reflections on surgical safety, local anaesthetic technique, and the state of dental education sit alongside something warmer: a life philosophy that's disarmingly simple. Stay curious.In This Episode00:02:50 - Four generations of dentists00:06:05 - Child dental health crisis00:07:20 - New grandmother00:10:00 - Choosing dentistry00:17:05 - Serendipity over ambition00:37:15 - The juggle: three kids and a PhD00:41:00 - Bullying and misogyny in surgery00:44:45 - King's: first chair in oral surgery00:47:35 - Multidisciplinary pain clinic00:49:25 - The Iranian patient00:56:00 - Trust underpins consent01:00:00 - Classifying orofacial pain01:07:05 - When grief resolves chronic pain01:12:15 - Blackbox thinking01:17:00 - Local anaesthetic tips01:22:00 - Wrong site surgery01:25:30 - Dental student selection01:27:15 - Redesigning the dental course01:47:50 - Bruxism: rethinking the evidence01:50:15 - Fantasy dinner party01:53:45 - Last days and legacyAbout Professor Tara Renton OBEProfessor Tara Renton OBE is Emeritus Professor of Oral Surgery at King's College London Dental Institute, where she became the first female chair of oral surgery — and one of the world's leading authorities on orofacial pain and nerve injury. Over a career spanning more than 40 years, she has authored over 250 research papers, completed a PhD centred on morbidity following third molar surgery, established a pioneering multidisciplinary pain clinic at King's, and carried out extensive medico-legal work in surgical safety. She is the co-founder of the patient resource orofacialpain.org.uk.

In this episode, host Shikha Jain, MD, speaks with Jessica MacIntyre, DNP, about her role and goals as president of the Oncology Nursing Society, multidisciplinary focuses within cancer care and more. ·       Welcome to another exciting episode of Oncology Overdrive 1:22 ·       About Jessica MacIntyre, DNP, MBA, APRN, AOCNP, FAANP 1:34 ·       The interview 2:50 ·       Tell me about how you got to where you are today […] What was your journey to becoming a nurse practitioner, and into the leadership role you hold today? 3:15 ·       What is Oncology Nursing Society (ONS)? What does it do, and how did you become president?  5:17 ·       What are your goals as president of ONS? 9:08 ·       Jain and MacIntyre on the importance of multidisciplinary approaches to cancer care. 12:28 ·       What excites you about the role of nurses and nurse practitioners, and the future of the oncology team as a whole? 14:34 ·       Where do you see the future of patient navigation going? […] Where do you see AI playing a role in all of this? 17:42 ·       What do you say to people who are scared of AI becoming all-encompassing? 20:41 ·       Jain and MacIntyre on embracing and improving the use of AI in cancer care. 22:14 ·       What do you recommend to nurses as they embark on their careers? […] How can we make sure nurses are working to the top of their license while supporting the cancer care team? 24:09 ·       Jain and MacIntyre on the increasing importance of advocacy in health care. 26:55 ·       If someone could only listen to the last minute of this episode, what would you want listeners to take away? 28:31 ·       How to contact MacIntyre 30:00 ·       Thanks for listening 30:56 Jessica MacIntyre, DNP, MBA, APRN, AOCNP, FAANP, is president of the Oncology Nursing Society and executive director of clinical operations at Sylvester Comprehensive Cancer Center, part of University of Miami Miller School of Medicine. We'd love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. MacIntyre can be reached on LinkedIn, or via email jmacintyre@med.miami.edu. Jain reports no relevant financial disclosures. MacIntyre reports compensation from Johnson & Johnson for participation on a nursing panel.

In this powerful episode, Dr. Lynn Hellerstein speaks with Glenn Sturm, bestselling author, astrophotographer, and 18 years on chemo and counting. Guided by values like “Sturms never quit,” Glenn shares how he pursues passion, spreads positivity, and refuses to let cancer define his life. He highlights the impact of a multidisciplinary cancer care team where specialists collaborate and patients are part of the decision-making. This approach can significantly reduce mortality and improve quality of life compared to solo care. From managing cancer fatigue to using simple remedies like ginger for nausea, Glenn shares practical ways to navigate treatment. Originally given 2.5 years to live, he's now looking at 30—crediting team-based care and self-advocacy. Despite its benefits, multidisciplinary care faces barriers like insurance and provider resistance particularly in the United States. While it's typical to find palliative care team and tumor boards in hospitals, it is more challenging to find a true multidisciplinary cancer care team. Glenn's mission is to raise awareness and encourage patients to seek better, more collaborative care through his books Warrior Hate War, Cancer Set Me Free and his upcoming work More Than Hope. Dr. Lynn Hellerstein, Developmental Optometrist, co-owner of Hellerstein & Brenner Vision Center, P.C., award-winning author and international speaker, holds powerful and inspiring conversations with her guests in the areas of health, wellness, education, sports and psychology. They share their inspirational stories of healing and transformation through their vision expansion. Vision Beyond Sight Podcast will help you see with clarity, gain courage and confidence. Welcome to Vision Beyond Sight! Also available on Apple Podcasts, iTunes, Google Podcasts, Spotify, iHeart Radio, Audible and Stitcher.

In this episode, Edward J. Dohring, M.D., of the Spine Institute of Arizona, discusses the value of multidisciplinary collaboration, emerging innovations in spine care, and the evolving role of AI and minimally invasive approaches. He also shares insights on improving patient outcomes, balancing cost and quality, and shaping the next generation of spine leaders.

Send us Fan MailPhoto of Zoë Buckman by Abbey Druckershow notes:1:10 background as a multi-media visual artist7:00 Buckman's dialogue with agency9:25 her use of embroidery10:40 filmmaking11:00 Show Me Your Bruises, Then14:25 exhibition at the Perez Museum 18:50 power of art22:00 Artist Tracey Ehmann  23:45 exploration of personal issues in her work 26:15 her work on Jewish personhood 34:30 erasure and gaslighting of Jewish artists37:00 show at Mindy Solomon Gallery 41:00 Jewish people's complicated relationship with the home42:45 her definition of justice / injustice 45:40 how her work addresses her view of justice / injustice49:30 use of vintage textiles51:45 coffee table book52:45 2027 NY show53:30 collaboration with Actress Cush Jumbo54:50 the legacy Buckman hopes to make with her work56:15 multiple truths she addresses in her workPlease share your comments and/or questions at stephanie@warfareofartandlaw.comMusic by Toulme.To hear more episodes, please visit Warfare of Art and Law podcast's website.To leave questions or comments about this or other episodes of the podcast and/or for information about joining the 2ND Saturday discussion on art, culture and justice, please message me at stephanie@warfareofartandlaw.com. Thanks so much for listening!This podcast and its content may not be used for training or developing AI systems without permission.© Stephanie Drawdy [2026]

Knitters and crocheters know Angela Tong as a designer with hooks and needles, while weavers recognize her work in rigid-heddle and pin looms. Visitors to galleries and artisan markets know her as a potter. Angela thinks of herself simply as a maker, always drawn to creating beauty with her hands. Her first professional job set the tone: after earning a degree from the Fashion Institute of Technology, she produced fine platinum jewelry for Tiffany & Co. But beginning in her teens, she keenly felt the urge to learn to knit. A colleague at that first job taught her the knit stitch—just the knit stitch—and opened the world of fiber arts for her. Discovering a talent for clarifying instructions while test knitting other designers' work, she began submitting designs for publication. Although she had not initially pictured herself as a teacher, that skill of clear explanation led her to teaching, and she eventually became a certified knitting instructor. Angela discovered another fiber-arts love in PieceWork March/April 2010, which featured pin looms on the cover. She tracked down a handmade pin loom from a small maker, wove a doll blanket, and never looked back. Her pin-loom and rigid-heddle designs regularly appear in Little Looms, and she is a popular instructor at Weave Together events. In each of her crafts, Angela's style is symmetrical and refined, with an emphasis on finishing that she describes as a through line in everything she makes, from pottery to pin-loom blankets. Whatever the medium, Angela brings the same exacting eye and genuine delight in craft — whether she's warping a loom, trimming a pot, or teaching a roomful of students to hem stitch. Links PieceWork March/April 2010 featured a pin-loom blanket on the cover. Angela's pin loom videos Creative Pin-Loom Designs and Weave Patterns on the Pin Loom are available from Long Thread Media. Angela was featured in the pilot episode of the proposed Swatch series. This episode is brought to you by: Treenway Silks is where weavers, spinners, knitters and stitchers find the silk they love. Select from the largest variety of silk spinning fibers, silk yarn, and silk threads & ribbons at TreenwaySilks.com. You'll discover a rainbow of colors, thoughtfully hand-dyed in Colorado. Love natural? Treenway's array of wild silks provide choices beyond white. If you love silk, you'll love Treenway Silks, where superior quality and customer service are guaranteed.

In this episode, Edward J. Dohring, M.D., of the Spine Institute of Arizona, discusses the value of multidisciplinary collaboration, emerging innovations in spine care, and the evolving role of AI and minimally invasive approaches. He also shares insights on improving patient outcomes, balancing cost and quality, and shaping the next generation of spine leaders.

In this episode, Edward J. Dohring, M.D., of the Spine Institute of Arizona, discusses the value of multidisciplinary collaboration, emerging innovations in spine care, and the evolving role of AI and minimally invasive approaches. He also shares insights on improving patient outcomes, balancing cost and quality, and shaping the next generation of spine leaders.

Experts discuss the different roles of clinicians in managing metabolic dysfunction-associated steatohepatitis (MASH). Credit available for this activity expires: 4/28/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/multidisciplinary-management-metabolic-dysfunction-2026a1000d62?ecd=bdc_podcast_libsyn_mscpedu

A child can need support and still have too much support. In this conversation, I talk with Casey Joseph, special educator and founder of Casey's Special Education Services, about what happens when families get handed a long list of recommendations and start trying to do all of it at once. Casey shares why "more" is not always the best answer for neurodivergent kids, especially when services start to crowd out rest, connection, regulation, and ordinary family life. We talk about the hidden cost of too many appointments, too many providers, and too many moving pieces, and why parents need permission to step back and ask what is truly necessary right now. We also get into the practical side of this: how to think about a child's most urgent needs first, why fit matters more than quantity, when it may make sense to pause or reduce services, and how seasons of life affect progress too. Casey offers a thoughtful framework for choosing support with more intention and less panic, so families can build something sustainable instead of piling on one more thing just because it sounds helpful. Key Takeaways More services do not automatically mean better outcomes. A child can benefit from support and still become overwhelmed by too many appointments, transitions, and expectations. Parents need permission to be intentional. It is okay to ask what is most important right now instead of trying to address every need at the same time. Burnout matters for kids too. If a child is spending all day holding it together at school, adding too many after-school supports can push them past capacity. Burnout in parents affects the whole system. When a parent is juggling too many providers, updates, schedules, and logistics, that stress often gets felt by the child. Fit matters as much as access. A therapist, tutor, or clinician may be wonderful and still not be the right person for a particular child or diagnosis. Support should match the real priority. Sometimes the first need is regulation, anxiety support, sensory support, or basic physical needs, not academics. Services can change over time. A child may need something intensely for one season, then need less, a break, or something different later. Progress is not linear. Some parts of the year are naturally harder, and families do not need to panic if growth looks slower during stressful or draining seasons. Multidisciplinary support can help when it reduces stress. Sometimes one clinic or one coordinated team makes more sense than managing many separate providers. A good question for families is not only "What could help?" but also "What is giving us a real return on the investment of time, money, and energy?" About Casey Joseph Casey Joseph is the Executive Director and Founder of Casey's Special Education Services, LLC. She is a special educator who has built a team of special education teachers providing one-on-one support, tutoring, and consultation for families across the DMV. Casey's work focuses on children who learn differently and benefit from individualized support grounded in special education expertise. Her approach is collaborative, strengths-based, and centered on helping families find support that is both meaningful and sustainable. About Your Host, Gabriele Nicolet I'm Gabriele Nicolet, toddler whisperer, speech therapist, parenting life coach, and host of Complicated Kids. Each week, I share practical, relationship-based strategies for raising kids with big feelings, big needs, and beautifully different brains. My goal is to help families move from surviving to thriving by building connection, confidence, and clarity at home. Complicated Kids Resources and Links

Sriwhana Spong, a New Zealand-born artist of Balinese heritage based in London, is presenting her first major solo exhibition in Australia at the Monash University Museum of Art in Melbourne. - Sriwhana Spong, seniman asal Selandia Baru berdarah Bali yang berbasis di London, menghadirkan pameran tunggal perdananya di Australia di Monash University Museum of Art, Melbourne.

In this episode, surgical oncologist Dr. Seth Concors of Emory's Winship Cancer Institute discusses the role of the surgical oncologist within the multidisciplinary care team for neuroendocrine cancer. We explore what surgical oncologists do, why NET-specific experience matters, how surgical decisions are made, and what patients can expect during a surgical consultation. The conversation highlights coordination across care teams, common patient concerns, and the importance of informed decision-making and second opinions, offering practical guidance for patients and caregivers navigating surgical care in neuroendocrine cancer.TOP TEN QUESTIONS Understanding the Surgeon's Role1. What is a surgical oncologist, and what kind of training does that involve? How is a surgical oncologist similar to—or different from—other types of surgeons? Patients may hear the term “HPB surgeon.” What does that mean, and how can a patient tell if their surgeon is an HPB surgeon? 2. When a patient is looking for a surgeon, how can they find someone who is the “right fit” for them? How can patients know whether a surgeon has experience with the specific operation they may need—such as a Whipple procedure, liver surgery, or lung surgery? How important is it for a surgeon to be familiar with neuroendocrine tumors specifically?3. What should patients expect at their first appointment with a surgical oncologist? What key information are you usually trying to communicate during that first visit? What questions do you encourage patients and caregivers to ask their surgeon?4. How often should patients expect to see their surgical oncologist, and at what points in their care?Surgical Decision-Making5. How do you determine whether someone is a surgical candidate?  What is the typical goal of surgery for neuroendocrine tumors?6. If someone is not a surgical candidate initially, does that mean surgery is off the table forever? Are there treatments that can help make surgery possible in the future? How many NET surgeries can someone safely have over their lifetime? Can major surgeries—such as extensive liver resections—affect eligibility for future treatment options?Multidisciplinary and Coordinated Care7. How do surgical oncologists work within a multidisciplinary care team for NET patients? How do you collaborate with providers at different institutions, such as a local oncologist working with a NET specialty center?8. What is your perspective on second opinions, specifically for neuroendocrine cancer?9. Many patients worry about carcinoid crisis during surgery. How do you address and manage those concerns?Preparing for Surgery10. Patients often ask how they can best prepare—physically and emotionally—for surgery. What guidance do you typically offer?BONUS: What research is currently being done involving neuroendocrine surgery?ABOUT THE SPEAKERSeth Concors, MD, is an academic surgical oncologist at Emory University and the Winship Cancer Institute, where he serves as Associate Program Director for both the General Surgery Residency and the Complex General Surgical Oncology Fellowship, and Director of the Surgical Oncology Research Fellowship. He leads Emory's Peritoneal Surface Malignancy and Neuroendocrine Tumor surgical programs, with clinical and research interests focused on gastrointestinal neuroendocrine tumors, cytoreductive surgery/HIPEC, and survivorship outcomes. Dr. Concors is actively involved in national surgical societies, including SSO, SSAT, NANETS, ACS, and ECOG-ACRIN, and his work emphasizes multidisciplinary collaboration, prospective outcomes research, and surgical education. He is committed to advancing patient-centered cancer care while mentoring the next generatioFor more information, visit NCF.net.